Difference between revisions of "CTSC:education Quantitative Imaging Biomarkers"
From NAMIC Wiki
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| + | Back to [[CTSC:education|Harvard Catalyst Imaging Working Group Education]] <br> | ||
| − | * Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials | + | == Quantitative imaging workshop ACRIN fall meeting, Arlington, VA, October 2009 == |
| + | |||
| + | * Dr Kasia Macura, Johns Hopkins [[media: macura.pdf| Overview of imaging biomarkers and their use in clinical trials]] | ||
* Dr Randy Gollub, Harvard MGH [[media: gollub.pdf| Generic principles of image registration, segmentation, visualization]] (technical aspects) | * Dr Randy Gollub, Harvard MGH [[media: gollub.pdf| Generic principles of image registration, segmentation, visualization]] (technical aspects) | ||
* Dr Jeff Yap, Harvard DFCI [[media: Yap.pdf| Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials]] (e.g. RSNA QIBA) | * Dr Jeff Yap, Harvard DFCI [[media: Yap.pdf| Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials]] (e.g. RSNA QIBA) | ||
Latest revision as of 19:55, 28 October 2010
Home < CTSC:education Quantitative Imaging BiomarkersBack to Harvard Catalyst Imaging Working Group Education
Quantitative imaging workshop ACRIN fall meeting, Arlington, VA, October 2009
- Dr Kasia Macura, Johns Hopkins Overview of imaging biomarkers and their use in clinical trials
- Dr Randy Gollub, Harvard MGH Generic principles of image registration, segmentation, visualization (technical aspects)
- Dr Jeff Yap, Harvard DFCI Description and case studies of each of the imaging biomarkers and requirements for standardized acquisition in multi-center trials (e.g. RSNA QIBA)
- DCE-MRI (pre/post-therapy breast tumor perfusion)
- volumetric CT (e.g. lung tumor segmentation and volumetric measurement)
- FDG-PET/CT (pre/post-therapy whole-body imaging with SUV quantification)
